bromoacetone has been researched along with benzyl bromide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bessac, BF; Caceres, AI; Escalera, J; Jordt, SE; Sivula, M; von Hehn, CA | 1 |
| Baraldi, PG; Geppetti, P; Materazzi, S; Preti, D | 1 |
1 review(s) available for bromoacetone and benzyl bromide
| Article | Year |
|---|---|
Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Asthma; Humans; Ion Channel Gating; Neurons; Pain; Peripheral Nervous System Diseases; Pulmonary Disease, Chronic Obstructive; Transient Receptor Potential Channels | 2010 |
1 other study(ies) available for bromoacetone and benzyl bromide
| Article | Year |
|---|---|
Transient receptor potential ankyrin 1 antagonists block the noxious effects of toxic industrial isocyanates and tear gases.
Topics: Animals; Cell Line; Cells, Cultured; CHO Cells; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Electrophysiology; Female; Ganglia, Spinal; Hypochlorous Acid; Isocyanates; Kidney; Male; Mice; Mice, Inbred C57BL; Neurons, Afferent; Oxidants; Patch-Clamp Techniques; Tear Gases; Transient Receptor Potential Channels; Trigeminal Ganglion; TRPA1 Cation Channel | 2009 |